This study investigates the role of body image self-appraisal in predicting the outcomes of outpatient psychotherapy in patients with anorexia nervosa (AN).
| INTRODUCTION
Body image disturbance is a central feature of the pathology of patients with anorexia nervosa (AN), which potentially perpetuates disordered eating behaviour and affective comorbidities such as anxiety and depression (American Psychiatric Association, 2013; Fairburn & Brownell, 2005; Junne et al., 2016) . Cash and Hrabosky (2004) define the concept of body image as the "multifaceted psychological experience of embodiment and body-related self-perceptions and selfattitudes including thoughts, beliefs, feelings and behaviors." The other concept, of body schema distortion in patients with AN, would typically be the subjective perception of a greater extent of, for example, the thighs than actually given. Recent evidence shows that the concept of a distorted quantitative body self-perception cannot fully be confirmed in patients with AN (Junne & Zipfel, 2017; . In contrast, the present study focuses on the role of the body image dimension, that is, the cognitive-emotional body image self-appraisal as operationalized by the Body Image Questionnaire (BIQ-20; Clement & Löwe, 1996a) .
Overall, the results of the existing literature underline the significant role that body image perceptions may play in the onset and course of AN (Benninghoven et al., 2006; Cazzato et al., 2016; Fernández, Turón, Siegfried, Meermann, & Vallejo, 1995; Fernández & Vandereycken, 1994; Marco, Perpina, & Botella, 2013) . However, it is unclear so far, what exact effects body image alterations might have on the complex interplay of disease modifying factors during AN treatment. In our recent work, we have shown that body image perceptions predict symptoms of depression and anxiety in the course of outpatient treatment in patients with AN (Junne et al., 2016) . On the basis of the latter findings, we hypothesize that body image dimensions predict eating disorder relevant outcomes such as the body mass index (BMI) directly or via the determination of affective symptoms in patients with AN.
The aim of this study therefore is to explore the influence of body image disturbance on treatment outcomes over the course of outpatient treatment of patients with AN. First, this study tests the hypothesis that body image perceptions directly predict treatment outcomes. Second, the study aims to identify potential sequential pathways in testing the hypothesis that body image disturbance leads to an increase in perceived stress, which leads to higher loads of affective symptoms (depression and anxiety) which in turn predict BMI and eating disorder pathology as outcomes of AN treatment. The latter hypothesis is tested using a path analysis based on a structural equation model.
The path model was developed on the basis of the theoretical considerations that body image disturbance represents a cognitive-emotional characteristic in patients with AN that can be seen as a core (primary) pathology of the disorder, eventually driving dysfunctional (restrictive) eating behaviour, stipulating purging behaviour, and hindering weight gain. Hence, it was assumed in Hypothesis 1 of this study that body image disturbance at baseline is a direct predictor of outcomes of AN treatment at follow-up measurements.
Besides the direct prediction of outcomes by body image distortion at baseline, Hypothesis 2 of this study assumes that there may be a sequential chain from (a) negative emotional body appraisal that may lead to (b) increased stress under treatment (while gaining weight) that leads to (c) higher symptom load of affective disorders (anxiety and depression) that may have an impact on (d) the treatment outcomes BMI and ED-pathology at follow-up stages.
To explore the interaction of body image appraisal and affective symptoms further, the dimension of perceived stress has been included in the path-analysis model to represent a potential link between negative body image self-appraisal and affective symptoms.
All analyses of this study are conducted as secondary analyses of the anorexia nervosa treatment of outpatient (ANTOP) study.
The ANTOP study is the worldwide largest randomized controlled trial investigating outpatient psychotherapy for patients with AN (Zipfel et al., 2014) . The results of the present secondary analyses of the ANTOP cohort aim to inform further basic research and body image directed clinical interventions alike, potentially stipulating the urgently needed advancement of specific treatment strategies for patients with AN.
| METHODS

| Aims and design of the ANTOP study
The ANTOP study was conducted as a randomized controlled multicenter trial comparing the efficacy of enhanced cognitive behavioural therapy (CBT-E) and focal psychodynamic psychotherapy (FPT) to optimized treatment as usual (TAU-O) in the outpatient psychotherapy of patients with AN (BMI > 15gk/m 2 ). For the results related to primary outcomes of the ANTOP study, see, for example, Zipfel et al. (2014) or Wild et al. (2016) . For an in-depth description of the design of the ANTOP study including, for example, detailed descriptions of the applied standardized diagnostic interviews, please see the published study protocol 
| Interventions of the ANTOP study
The applied interventions in the ANTOP-treatment arms, that is, CBT-E and FPT were based on formalized treatment manuals (Fairburn, 2008; Schauenburg, Friederich, Wild, Zipfel, & Herzog, 2009 ; see also Zipfel et al., 2014) . Within the control condition (TAU-O) patients received optimized support to enter regular outpatient therapy with therapists who were experienced in treating patients with eating disorders. The treatment duration was 10 months in all of the intervention arms. See Zipfel et al. (2014) for further details on the ANTOP interventions.
| Measurements and outcomes
An extensive set of standardized instruments were administered during the ANTOP study at five measurement time-points: t0 = baseline measurement before randomization, t1 = 4 months in treatment, t2 = 10 months in treatment/end of treatment, t3 = 3 months follow-up (t2 + 3 months), and t4 = 1 year follow-up (t2 + 12 months). The outcome dimensions included in the present secondary analyses include the BMI (BMI = body weight in kg divided by body height in m 2 ) and the sum score of the Eating Disorder Inventory (EDI-2; Paul & Thiel, 2004) . The two subscales of the Body Image Questionnaire (BIQ-20) were used to represent body image disturbances as independent variables within the regression analyses and as exogenous factors within the path analysis (structural equation model) to test the hypotheses of outcomeprediction (Clement & Löwe, 1996a; Clement & Löwe, 1996b) . In the context of the path analysis the respective subscales of the Patient Health Questionnaire (PHQ) were used to include the factors (a) perceived stress, (b) depressive symptom load (PHQ-9), and (c) symptoms of anxiety (GAD-7; Löwe et al., 2008; Spitzer et al., 1999; Spitzer, Kroenke, Williams, & Löwe, 2006) . The applied instruments are described in the following.
| The Eating Disorder Inventory-2
The EDI-2 represents a standard self-administered multidimensional questionnaire to detect eating disorders relevant pathology (Paul & Thiel, 2004) .
Values for internal consistency are reported with Cronbach's α 0.96 in a clinical sample and Cronbach's α 0.94 and 0.90 for female and male healthy controls, respectively (Thiel & Paul, 2006) . In the context of these secondary analyses of the ANTOP cohort, the EDI-2 was used as the main outcome parameter besides BMI.
| The Body Image Questionnaire (BIQ-20)
The Body Image Questionnaire (BIQ-20) was developed by Löwe (1996a, 1996b) to assess the subjective perceptions of the body self in its cognitive-emotional and attitudinal dimensions. The instrument was validated in a broad set of patient and general population cohorts (Albani et al., 2006) . The questionnaire consists of two subscales "Negative Evaluation of the Body (NEB)" and "Perception of Body Dynamics (PBD)" with 10 individual items per subscale.
The subscale "Negative Evaluation of the Body (NEB)" captures the more negative views and attitudes towards one's own body (item examples: "I am dissatisfied with my body"; "I do not like myself in photographs"). The subscale "Perception of Body Dynamics" is constructed to determine the more positive appraisal of the body self-perception (item examples: "In general I feel robust and strong"; "I feel at home in my body").
In the ANTOP cohort, internal consistencies for the BIQ-20 across different measurement time-points ranged from Cronbach's α 0.87 to 0.93 for the subscale NEB and Cronbach's α 0.83 to 0.92 for the subscale PBD.
| The Patient Health Questionnaire
The PHQ is seen to be a gold-standard diagnostic questionnaire to detect relevant symptoms of mental disorders and their context factors including anxiety, depression, eating disorders, and perceived stress (Löwe et al., 2008) . The subscales of the PHQ are based on the DSM-IV diagnostic criteria and may all be analysed and applied independently of the rest of the PHQinstrument.
For the purpose of this study, the PHQ subscales for (a) stress, (b) depression (PHQ-9), and (c) symptoms of anxiety (GAD-7) were applied as sequential factors within the here hypothesized path-analysis model.
| Statistical analyses
To describe the subsample of the ANTOP cohort, means, standard deviations, and percentages are reported in terms of demographic characteristics and other relevant variables. Analyses of variance for repeated measures were applied to test for differences of means between treatment arms and measurement time-points for the investigated dimensions. The level of significance for all analyses was set at α = 0.05. All statistical analyses were performed using IBM SPSS Statistics® version 24.
| Predictor analyses
Linear regression analyses were applied to test the Hypothesis 1 of this study, which assumes that body image at baseline predicts outcomes of AN treatment at follow-up. The model was controlled for both outcome parameters (BMI and EDI-2) at baseline, respectively.
| Path analyses and model development
To test the second hypotheses of this study, a path-analytic-model was formulated on the basis of theoretical and empirical considerations. Hypothesis 2 of this study is represented by the assumption that there is a sequential longitudinal relationship of (a) body image disturbance at baseline to (b) perceived stress under treatment to (c) affective symptom load (depression and anxiety) at later treatment stages to (d) treatment outcomes (BMI and EDI-2) at follow-up measurements.
The path analysis was performed to test the direct dependencies between the hypothesized variables in one model using AMOS 21.0 for SPSS®.
Four chronological stages were represented in the path model: The BIQ-20 subscales NEB and PBD at baseline are the starting point with BMI and EDI-2 sum score as control variables at baseline. At the second sequential stage, stress at 4 months in treatment (t1) was incorporated. At the third sequential stage, depression and anxiety symptoms at the end of the psychotherapeutic intervention (10-month-in-treatment measurement; t2) were included. Finally, the outcomes BMI and EDI-2 served as the fourth sequential stage at 1-year follow-up after treatment (t4).
In the finally established model, PHQ stress t1, PHQ depression t2, PHQ anxiety t2, EDI-2 sum-score t4, and BMI t4 are included as endogenous (dependent) variables whereas NEB, EDI-2 sum score, and BMI at baseline (t0), respectively, are included as exogenous (independent) variables. Maximum likelihood estimation was used as discrepancy function. A chi-square test is used as a model test, and the comparative fit index and the root mean square error of approximation are reported as indices of model fit. Model results are reported graphically where all relevant (significant) paths were depicted with individual regression weights, besides a comprehensive table of results for the final path analysis.
| RESULTS
The ANTOP cohort comprises a total of N = 242 females between the ages 18 and 56. In this study, we report on the subsample of the ANTOP study cohort that was eligible to be included into our path analysis based on the completeness of all included data sets. This subsample comprises n = 148 females, for an overview of the baseline characteristics, see Table 1 . The here described subsample of the ANTOP cohort does not differ significantly from the rest of the ANTOP cohort with regard to the baseline characteristics, and hence, the investigated subsample is seen to be representative of the ANTOP cohort.
For an overview of the distributions (means and standard deviations) for all included variables, see Table 2 .
All of the included variables showed a significant main effect of measurement time-points in the performed analysis of variance for repeated measures, PHQ: depres- , and stress all decreased, meaning that participants indicated less symptoms of depression, anxiety, and stress over the course of the study. Finally, concerning our outcome measures, the EDI-2 sum score decreased over measurement time-points, F (3, 367) = 41.94, p < 0.001, η 2 = 0.228, whereas the BMI increased, F (2, 313) = 44.48, p < 0.001, η 2 = 0.239, indicating an improvement over time for eating disorder cognitions and weight. For a graphical illustration of the changes across the investigated variables, see Figure 1 . There was no difference with regard to systematic changes of NEB nor PBD across the three different treatment modalities (CBT-E, FPT, and TAU-0), and hence, the analyses conducted here were done in including patients across all three treatment arms.
The linear regression models comprised BMI at t4 or the EDI-2 sum score at t4 as outcome (dependent variables) and NEB at t0, PBD at t0 as predictors together with the respective dependent variable (BMI or EDI-2 at t0) as control variables. In both models, the only significant direct predictor of outcome at follow-up was the respective outcome at baseline (BMI t0: standardized β = 0.37, p < 0.001; EDI-2 sum-score t0: standardized β = 0.58, p < 0.001), and no significant prediction of neither NEB nor PBD was found. Therefore, in this sample, there is no direct prediction of BMI and EDI-2 at 1-year follow-up by the body image scales NEB and PBD at baseline.
Subsequently, the hypothesized path-analysis model was run to test Hypothesis 2 and to investigate the interplay of the hypothesized factors. Following the first path analysis run, nonsignificant pathways/variables were eliminated. The only variable that showed no direct relationship with any other hypothesized factor was the PBD subscale of the BIQ-20 representing the Perception of Body Dynamics at baseline (t0). The path that proved not to be significant as hypothesized was the prediction of outcomes (BMI and EDI-2) at follow-up by anxiety at late treatment stages. Hence, this path was not depicted in the final model. Figure 2 . Skew for all variables is <2 and kurtosis for all <7, a multivariate normal distribution can therefore be assumed. The model test proves to be significant with χ 2 (16) = 27.42, p = 0.037, which would advise to critically question the hypothesized model. However, because the model complexity is high, and the number of sequential levels and included variables is very high, the value of the χ 2 model test should carefully be interpreted in this case. Given that in this case the ratio of χ 2 to degrees of freedom is <2 the model can be accepted as good (Tabachnick & Fidell, 2013) . Furthermore, the indices for model fit with comparative fit index = 0.971 indicate a good model fit and with root mean square error of approximation = 0.070 indicating an acceptable model fit. Hence, it can be argued that the established model fits the data. All depicted paths in the final model ( Figure 2 ) were significant below the ps ≤ 0.001 level. For a detailed overview of the unstandardized and standardized regression weights of the included paths, see Table 3 .
The final model for the path analysis is shown in
Notably, NEB at baseline (t0) is directly predicting all three PHQ subscales at later treatment stages: PHQ stress at t1 (4 months in treatment) and PHQ depression and anxiety at t2 (end of treatment). PHQ stress t1 in turn predicts PHQ depression and PHQ anxiety at t2. None of the paths that lead to PHQ anxiety t2 are directly associated with the two outcome measures BMI and EDI-2 at the 1-year follow-up (t4). Whereas the paths leading from PHQ depression at t2 to both outcome measures predict both BMI and eating disorder pathology (EDI-2) in the expected directions. The association of PHQ depression t2 and BMI t4 is negative with a standardized regression weight of β = −0.24 indicating that lower symptoms of depression at the end of treatment are associated with a higher BMI at 1-year follow-up. The association of PHQ depression t2 and EDI-2 sum-score t4 is positive with a standardized regression weight of β = 0.31 indicating that lower symptoms of depression at the end of treatment are associated with a lower EDI-2 sum score at 1-year follow-up. In summary, the hypothesized model of sequential longitudinal relationships of body image disturbance via perceived stress and affective symptoms to treatment outcomes in patients with AN has been confirmed on the basis of this analysis for pathway: (a) Negative Evaluation of the Body (NEB)-Stress-Depression-Eating Disorder Outcomes (BMI & EDI-2) and pathway (b) Negative Evaluation of the Body (NEB)-Depression-Outcomes (BMI & EDI-2).
| DISCUSSION
This is the first study to analyse the relationship of body image disturbance with experienced stress, affective symptoms, and treatment outcomes longitudinally in a large outpatient-treatment sample of patients with AN. The results show that body image disturbances play a significant role in the determination of outcomes of AN treatment via the determination of variance of experienced stress and affective symptoms.
The dimension of the BIQ-20 that proved to be predictive in the path model was the dimension of Negative Evaluation of the Body (NEB). The Positive Evaluation of the Body (PBD) was not confirmed as a relevant predictor of neither stress nor affective symptoms nor treatment outcomes. The differential importance of the two subscales might be due to the fact that the two subconstructs of the BIQ-20 are no linear opposing constructs but capture different qualitative perspectives of the body self-appraisal. The NEB seems to capture the typical body self-appraisal issues of patients with AN and hence might be of more relevance for the prediction of outcomes. The fact that symptoms of anxiety were not predicted by body-selfappraisal can be seen as a rather surprising result. It might be understood in the sense that general anxiety symptoms are too broad to capture the more specific fears of patients with AN (fear of gaining weight, fear to eat) and hence may not detect adequately body-related anxiety of patients with AN. Reflecting the results on our own recent work (Junne et al., 2016; Mölbert, Klein, et al., 2017) , the here presented results underline the importance of cognitive-emotional body image perceptions for treatment outcomes in patients with AN.
With regard to the relationship of body image selfappraisal and symptoms of depression, one might speculate whether this might be bidirectional, that is, higher symptom load of depression may vice versa worsen negative body self-appraisal. However, given the confirmation of the hypothesized sequential pathway from negative body image via the variable of perceived stress to affective symptoms, at least the here investigated direction of potential influence seems valid on theoretical and empirical grounds.
Further support for the relevance of body image for comorbid depression in patients with AN is found by Delinsky and Wilson (2006) who showed that specifically body image directed interventions reduced symptoms of depression in patients with AN (see also Benninghoven et al., 2006) . These findings may encourage to delineate the clinical implication that patients with AN should receive explicit body image directed interventions as part of psychotherapeutic treatments.
However, given the findings of the here presented study, the adverse effects of eventually increased stress levels in patients with AN when explicitly focusing on body image self-appraisal during psychotherapeutic interventions, do point to the risk of adverse effects, if increased stress (by,e.g., mirror exposure) subsequently leads to worsening of affective comorbidities (and not to the intended habituation) and hence to less favourable treatment outcomes. Furthermore, one might contemplate to promote positive bodily experiences through physiotherapy or weight adjusted gymnastics, or yoga for patients with AN (Douglass, 2009) .
To account for the relationship of negative body image and stress, body image directed psychotherapeutic interventions could be combined with explicit stress reduction trainings such as progressive muscle relaxation or mindfulness based stress reduction. Fernández and Vandereycken (1994) presented the first study on video-feedback training for patients with AN in a cognitive behavioural setting. The authors reported that patients with AN showed a more realistic assumption of their own body size than before the intervention and hence might have less denial of illness.
For example, video feedback as applied by Fernández and Vandereycken (1994) or feedback using biometric self-avatars in virtual reality ) may be combined with biofeedback interventions to explicitly work on stress-control and stress reduction while being exposed to pictures or avatars of one's own body in patients with AN. Such innovative virtual-reality applications where patients are able to morph their selfavatars to higher BMI levels and expose themselves to a larger body shape (see might overcome the shortfalls of analog mirror exposure, where patients may eventually habituate to their thin body and hence the barriers to weight gain may even be worsened. Analog mirror exposure may therefore be suitable at higher BMI levels in patients with AN (BMI > 16 kg/m 2 ).
With regard to exposure therapies, Koskina, Campbell, and Schmidt (2013) conducted a systematic review and inter alia point to the potential of virtual-reality settings for exposure techniques (see also Marco et al., 2013) . LewisSmith, Diedrichs, Rumsey, and Harcourt (2016) as a result of their systematic review on body image interventions again in general call for more rigourous research on interventions in the field of body image in patients with AN.
| LIMITATIONS
The analyses are limited with regard to the design as secondary analyses. However, the conduct and design of the ANTOP study comply with the highest aspirations, and the study represents the worldwide largest randomized controlled trial on the matter. As further limitations can be seen that the interventions applied in the ANTOP study (FPT and CBT-E) were designed to stipulate change towards improvement in AN-pathology but did not entail mandatory modules of explicit body image directed techniques or interventions. Group comparison across treatment arms in the ANTOP study did neither show significant nor systematic differences with regard to body image changes between the three treatment modalities, and hence, full sample analyses seemed justifiable with regard to the here investigated study questions and hypotheses. Furthermore, it is to note that only a subsample could be included in these secondary analyses. Albeit the comparison of the subsample with the full ANTOP sample regarding demographics showed that the subsample seems representative of the full cohort, it remains possible that there are biases associated with the selection based on data completeness. A further limitation of the study is that the potential further factors that might influence affective comorbidity of patients with AN could not be included in these analyses.
| CONCLUSION
The results of this study underline the importance of body image disturbance in the course of psychotherapeutic treatment in patients with AN. The results show that Negative Evaluation of the Body (NEB) does impact on stress and depressive symptoms, which in turn lead to less favourable outcomes in patients with AN in outpatient psychotherapy. Given these findings, specific targeting of body image dimensions in the treatment of patients with AN can be supported. However, given the potential adverse effects on stress, affective symptoms and outcomes in patients with AN, body image directed interventions should be accompanied by explicit strategies for stress reduction. Exposure techniques such as video feedback or avatar-exposition can, for example, be integrated into biofeedback techniques to enable patients to control and reduce stress levels during body image reflections. 
